Business

Axita Cotton Limited Achieves Record-breaking Revenue and Profit in FY2023-2024, Declares 10% Dividend

Apr 25, 2024

NewsVoir
Ahmedabad (Gujarat) [India], April 25: Axita Cotton Limited's Revenue skyrocketed to a staggering Rs. 1104 Crore, a remarkable 100.89% Y-o-Y increased as compared to Rs. 549.83 Crore. This impressive feat underscore Axita Cotton's commitment to exceeding expectations and delivering exceptional value.
* Yearly Net Profit at Rs. 20.58 crore in Year 2023-2024 up 20.49% from Rs. 17.08 crore in Year 2022-2023.
* EBITDA stands at Rs. 29.36 crore in Year 2023-2024 up 20.27% from Rs. 24.41 crore in Year 2022-2023.
Commenting on the results, Nitinbhai Govindbhai Patel, Chairman, Axita Cotton Limited said, "We're delighted to report surpassing a significant revenue milestone of Rs. 1104.38 in FY2024. This success is a result of our team's exceptional execution and the growing adoption of Technologies. Looking ahead, our unwavering commitment lies in seamlessly integrating our acquisitions, meticulously following our strategic roadmap, and fostering sustainable, profitable revenue growth."
In an affirmative move and a robust financial gesture that has resonated well with the market, Axita Cotton Limited. has announced a 10% dividend for FY2023-2024, a decision that has been perceived as a shining indicator of the company's financial health.
The announcement of the dividend has been perceived positively by the market, as it underscores the company's strong sales growth and profitability. It is not merely a distribution of profits but also a reinforcement of the company's potential for sustained growth and profitability in the future.
Highlights of FY:2023-2024

For more information, please visit www.axitacotton.com.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same)

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024